Gilead Sciences Earnings Preview: What to Expect

Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company headquartered in Foster City, California, known for discovering, developing, and commercializing innovative medicines that address serious unmet medical needs in areas such as HIV/AIDS, viral hepatitis, COVID-19, oncology, and inflammation. Gilead Sciences has a market cap of around $155 billion, reflecting its position as a significant player in the healthcare and biotechnology sectors. The company is set to announce its fiscal Q4 earni ...